We are live on
!
Find out more
SH
Sandia Holdings Portfolio holdings
AUM
$213M
1-Year Est. Return
29.35%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
–
Cap. Flow
+$187M
Cap. Flow
% of AUM
100.96%
Top 10 Holdings %
Top 10 Hldgs %
68.86%
Holding
23
New
23
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$21.1M |
| 2 |
Visa
V
|
+$16.1M |
| 3 |
AGN
Allergan plc
AGN
|
+$14.8M |
| 4 |
Liberty Latin America Class C
LILAK
|
+$12.5M |
| 5 |
Verisk Analytics
VRSK
|
+$12.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.96% |
| 2 | Financials | 22.48% |
| 3 | Industrials | 20.97% |
| 4 | Communication Services | 15.22% |
| 5 | Real Estate | 6.54% |
Similar funds
LFR
CT
SCM
LGC
KSA
TCM
FIM
CA
Sandia Holdings's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for Sandia Holdings, which disclosed 23 positions worth $185M. Its ten largest holdings account for 69% of the portfolio.
Its largest position is Blueprint Medicines: 700,991 shares worth $19.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Financials and Industrials.
- Sandia Holdings's largest Q4 2016 buy was Blueprint Medicines: 700,991 shares worth $19.7M.
- Sandia Holdings's ten largest holdings make up 69% of its $185M portfolio in Q4 2016.
- Sandia Holdings disclosed 23 positions in Q4 2016, its first 13F filing on record.
Based on Sandia Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.